img

Global SPECT Radiopharmaceuticals Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 113 | Industry : Pharma & Healthcare

Publisher : QY | Format : PDF

Global SPECT Radiopharmaceuticals Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other


Segment by Application


Oncology
Cardiology
Thyroid

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E




By Company


GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences

Table of Content

1 SPECT Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of SPECT Radiopharmaceuticals
1.2 SPECT Radiopharmaceuticals Segment by Type
1.2.1 Global SPECT Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Technetium-99
1.2.3 Thallium-201
1.2.4 Gallium-67
1.2.5 Iodine-123
1.2.6 Indium-111
1.2.7 Other
1.3 SPECT Radiopharmaceuticals Segment by Application
1.3.1 SPECT Radiopharmaceuticals Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Thyroid
1.4 Global SPECT Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global SPECT Radiopharmaceuticals Revenue 2016-2027
1.4.2 Global SPECT Radiopharmaceuticals Sales 2016-2027
1.4.3 SPECT Radiopharmaceuticals Market Size by Region: 2016 Versus 2021 Versus 2027

2 SPECT Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global SPECT Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
2.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)
2.3 Global SPECT Radiopharmaceuticals Average Price by Manufacturers (2016-2021)
2.4 Manufacturers SPECT Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 SPECT Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 SPECT Radiopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest SPECT Radiopharmaceuticals Players Market Share by Revenue
2.5.3 Global SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 SPECT Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global SPECT Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America SPECT Radiopharmaceuticals Sales by Country
3.3.2 North America SPECT Radiopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe SPECT Radiopharmaceuticals Sales by Country
3.4.2 Europe SPECT Radiopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific SPECT Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific SPECT Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific SPECT Radiopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America SPECT Radiopharmaceuticals Sales by Country
3.6.2 Latin America SPECT Radiopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa SPECT Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa SPECT Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global SPECT Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global SPECT Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.3 Global SPECT Radiopharmaceuticals Price by Type (2016-2021)

5 Global SPECT Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global SPECT Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.2 Global SPECT Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.3 Global SPECT Radiopharmaceuticals Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GE Healthcare Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Cardinal Health
6.2.1 Cardinal Health Corporation Information
6.2.2 Cardinal Health Description and Business Overview
6.2.3 Cardinal Health SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Cardinal Health Product Portfolio
6.2.5 Cardinal Health Recent Developments/Updates
6.3 Lantheus Medical Imaging
6.3.1 Lantheus Medical Imaging Corporation Information
6.3.2 Lantheus Medical Imaging Description and Business Overview
6.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Lantheus Medical Imaging Product Portfolio
6.3.5 Lantheus Medical Imaging Recent Developments/Updates
6.4 Bracco Imaging
6.4.1 Bracco Imaging Corporation Information
6.4.2 Bracco Imaging Description and Business Overview
6.4.3 Bracco Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bracco Imaging Product Portfolio
6.4.5 Bracco Imaging Recent Developments/Updates
6.5 Eczacibasi-Monrol Nuclear Products
6.5.1 Eczacibasi-Monrol Nuclear Products Corporation Information
6.5.2 Eczacibasi-Monrol Nuclear Products Description and Business Overview
6.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Eczacibasi-Monrol Nuclear Products Product Portfolio
6.5.5 Eczacibasi-Monrol Nuclear Products Recent Developments/Updates
6.6 IBA Molecular Imaging
6.6.1 IBA Molecular Imaging Corporation Information
6.6.2 IBA Molecular Imaging Description and Business Overview
6.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.6.4 IBA Molecular Imaging Product Portfolio
6.6.5 IBA Molecular Imaging Recent Developments/Updates
6.7 Jubilant Life Sciences
6.6.1 Jubilant Life Sciences Corporation Information
6.6.2 Jubilant Life Sciences Description and Business Overview
6.6.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jubilant Life Sciences Product Portfolio
6.7.5 Jubilant Life Sciences Recent Developments/Updates

7 SPECT Radiopharmaceuticals Manufacturing Cost Analysis
7.1 SPECT Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of SPECT Radiopharmaceuticals
7.4 SPECT Radiopharmaceuticals Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 SPECT Radiopharmaceuticals Distributors List
8.3 SPECT Radiopharmaceuticals Customers

9 SPECT Radiopharmaceuticals Market Dynamics
9.1 SPECT Radiopharmaceuticals Industry Trends
9.2 SPECT Radiopharmaceuticals Growth Drivers
9.3 SPECT Radiopharmaceuticals Market Challenges
9.4 SPECT Radiopharmaceuticals Market Restraints

10 Global Market Forecast
10.1 SPECT Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of SPECT Radiopharmaceuticals by Type (2022-2027)
10.1.2 Global Forecasted Revenue of SPECT Radiopharmaceuticals by Type (2022-2027)
10.2 SPECT Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of SPECT Radiopharmaceuticals by Application (2022-2027)
10.2.2 Global Forecasted Revenue of SPECT Radiopharmaceuticals by Application (2022-2027)
10.3 SPECT Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of SPECT Radiopharmaceuticals by Region (2022-2027)
10.3.2 Global Forecasted Revenue of SPECT Radiopharmaceuticals by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global SPECT Radiopharmaceuticals Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global SPECT Radiopharmaceuticals Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global SPECT Radiopharmaceuticals Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers SPECT Radiopharmaceuticals Covered in This Study
Table 5. Global SPECT Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global SPECT Radiopharmaceuticals Sales Share by Manufacturers (2016-2021)
Table 7. Global SPECT Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market SPECT Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers SPECT Radiopharmaceuticals Manufacturing Sites and Area Served
Table 11. Manufacturers SPECT Radiopharmaceuticals Product Type
Table 12. Global SPECT Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global SPECT Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in SPECT Radiopharmaceuticals as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global SPECT Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 16. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 17. Global SPECT Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America SPECT Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 19. North America SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 20. North America SPECT Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 22. Europe SPECT Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 23. Europe SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 24. Europe SPECT Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific SPECT Radiopharmaceuticals Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific SPECT Radiopharmaceuticals Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Table 30. Latin America SPECT Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 31. Latin America SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 32. Latin America SPECT Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa SPECT Radiopharmaceuticals Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa SPECT Radiopharmaceuticals Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa SPECT Radiopharmaceuticals Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa SPECT Radiopharmaceuticals Revenue Market Share by Country (2016-2021)
Table 38. Global SPECT Radiopharmaceuticals Sales (K Units) by Type (2016-2021)
Table 39. Global SPECT Radiopharmaceuticals Sales Market Share by Type (2016-2021)
Table 40. Global SPECT Radiopharmaceuticals Revenue (Million US$) by Type (2016-2021)
Table 41. Global SPECT Radiopharmaceuticals Revenue Share by Type (2016-2021)
Table 42. Global SPECT Radiopharmaceuticals Price (USD/Unit) by Type (2016-2021)
Table 43. Global SPECT Radiopharmaceuticals Sales (K Units) by Application (2016-2021)
Table 44. Global SPECT Radiopharmaceuticals Sales Market Share by Application (2016-2021)
Table 45. Global SPECT Radiopharmaceuticals Revenue (Million US$) by Application (2016-2021)
Table 46. Global SPECT Radiopharmaceuticals Revenue Share by Application (2016-2021)
Table 47. Global SPECT Radiopharmaceuticals Price (USD/Unit) by Application (2016-2021)
Table 48. GE Healthcare Corporation Information
Table 49. GE Healthcare Description and Business Overview
Table 50. GE Healthcare SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GE Healthcare SPECT Radiopharmaceuticals Product
Table 52. GE Healthcare Recent Developments/Updates
Table 53. Cardinal Health Corporation Information
Table 54. Cardinal Health Description and Business Overview
Table 55. Cardinal Health SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Cardinal Health SPECT Radiopharmaceuticals Product
Table 57. Cardinal Health Recent Developments/Updates
Table 58. Lantheus Medical Imaging Corporation Information
Table 59. Lantheus Medical Imaging Description and Business Overview
Table 60. Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Lantheus Medical Imaging SPECT Radiopharmaceuticals Product
Table 62. Lantheus Medical Imaging Recent Developments/Updates
Table 63. Bracco Imaging Corporation Information
Table 64. Bracco Imaging Description and Business Overview
Table 65. Bracco Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Bracco Imaging SPECT Radiopharmaceuticals Product
Table 67. Bracco Imaging Recent Developments/Updates
Table 68. Eczacibasi-Monrol Nuclear Products Corporation Information
Table 69. Eczacibasi-Monrol Nuclear Products Description and Business Overview
Table 70. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product
Table 72. Eczacibasi-Monrol Nuclear Products Recent Developments/Updates
Table 73. IBA Molecular Imaging Corporation Information
Table 74. IBA Molecular Imaging Description and Business Overview
Table 75. IBA Molecular Imaging SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. IBA Molecular Imaging SPECT Radiopharmaceuticals Product
Table 77. IBA Molecular Imaging Recent Developments/Updates
Table 78. Jubilant Life Sciences Corporation Information
Table 79. Jubilant Life Sciences Description and Business Overview
Table 80. Jubilant Life Sciences SPECT Radiopharmaceuticals Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Jubilant Life Sciences SPECT Radiopharmaceuticals Product
Table 82. Jubilant Life Sciences Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. SPECT Radiopharmaceuticals Distributors List
Table 86. SPECT Radiopharmaceuticals Customers List
Table 87. SPECT Radiopharmaceuticals Market Trends
Table 88. SPECT Radiopharmaceuticals Growth Drivers
Table 89. SPECT Radiopharmaceuticals Market Restraints
Table 90. Global SPECT Radiopharmaceuticals Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Type (2022-2027)
Table 92. Global SPECT Radiopharmaceuticals Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global SPECT Radiopharmaceuticals Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global SPECT Radiopharmaceuticals Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Application (2022-2027)
Table 96. Global SPECT Radiopharmaceuticals Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global SPECT Radiopharmaceuticals Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global SPECT Radiopharmaceuticals Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global SPECT Radiopharmaceuticals Sales Market Share Forecast by Region (2022-2027)
Table 100. Global SPECT Radiopharmaceuticals Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global SPECT Radiopharmaceuticals Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of SPECT Radiopharmaceuticals
Figure 2. Global SPECT Radiopharmaceuticals Market Share by Type in 2020 & 2027
Figure 3. Technetium-99 Product Picture
Figure 4. Thallium-201 Product Picture
Figure 5. Gallium-67 Product Picture
Figure 6. Iodine-123 Product Picture
Figure 7. Indium-111 Product Picture
Figure 8. Other Product Picture
Figure 9. Global SPECT Radiopharmaceuticals Market Share by Application in 2020 & 2027
Figure 10. Oncology
Figure 11. Cardiology
Figure 12. Thyroid
Figure 13. Global SPECT Radiopharmaceuticals Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global SPECT Radiopharmaceuticals Market Size 2016-2027 (US$ Million)
Figure 15. Global SPECT Radiopharmaceuticals Sales 2016-2027 (K Units)
Figure 16. Global SPECT Radiopharmaceuticals Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. SPECT Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 18. Global SPECT Radiopharmaceuticals Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest SPECT Radiopharmaceuticals Players: Market Share by Revenue in 2020
Figure 20. SPECT Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global SPECT Radiopharmaceuticals Sales Market Share by Region (2016-2021)
Figure 22. Global SPECT Radiopharmaceuticals Sales Market Share by Region in 2020
Figure 23. Global SPECT Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
Figure 24. Global SPECT Radiopharmaceuticals Revenue Market Share by Region in 2020
Figure 25. U.S. SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E SPECT Radiopharmaceuticals Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of SPECT Radiopharmaceuticals by Type (2016-2021)
Figure 50. Sales Market Share of SPECT Radiopharmaceuticals by Application (2016-2021)
Figure 51. Sales Market Share of SPECT Radiopharmaceuticals by Application in 2020
Figure 52. Revenue Share of SPECT Radiopharmaceuticals by Application (2016-2021)
Figure 53. Revenue Share of SPECT Radiopharmaceuticals by Application in 2020
Figure 54. Manufacturing Cost Structure of SPECT Radiopharmaceuticals
Figure 55. Manufacturing Process Analysis of SPECT Radiopharmaceuticals
Figure 56. SPECT Radiopharmaceuticals Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed